# K033052: Conductive Eeg Electrolyte

- Pathway: 510(k) (Abbreviated)
- Applicant: Compumedics USA, Ltd.
- Decided: Dec 17, 2003 after 79 days
- Product code: GYB (Media, Electroconductive)
- Device class: 2
- Regulation: 21 CFR 882.1275
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 2 generations back to K983964 (1998). 3 ancestors in all.
9 later devices descend from it; 1 cites it directly.
0 of 13 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K022006: Conductive Gel, The Dezac Group (2002) Summary page 1.
- K883149: TEN20 Conductive, Weaver & Co. (1988) Summary page 1.

## Most influential descendants
- K111717: Electro-Gel (2012), 8 descendants of its own
- K190050: Tech Dots - Adhesive and conductive gel (2019), 6 descendants of its own
- K192606: SAC2 - Electrode Cream (2020), 2 descendants of its own
- K161715: EndyGel (2017), 2 descendants of its own
- K200402: DR-HO'S Electro Therapy Conductive Gel (2020), 1 descendant of its own

## Indications for use
The Quik gel is intended to enhance electrical conductivity by facilitating transmission of the electrophysiological signals from the patient to the equipment to reduce impedance at the electrode-to-skin interface. It also helps the Quik cap electrodes adhere to the patient.

Source page: https://510kreport.com/device/K033052
Methodology: https://510kreport.com/methodology